These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Tamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses.
    Author: Nargund VH, Grey AD.
    Journal: Expert Opin Pharmacother; 2008 Apr; 9(5):813-24. PubMed ID: 18345957.
    Abstract:
    BACKGROUND: Although tamsulosin is mainly used to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia, with better understanding of functional anatomy and distribution of alpha(1) receptors, it is also indicated in other conditions of genito-urinary tract in both men and women. OBJECTIVE: To detail the therapeutic use and clinical effects of tamsulosin. METHODS: The scope of the review was related to tamsulosin and its therapeutic application in conditions of genitourinary tract. Publications were searched from Pubmed and Medline from 1975 to 2007 using the search words tamsulosin, lower urinary tract symptoms, alpha receptors and blockers. CONCLUSIONS: The management of benign prostatic hyperplasia was transurethral resection of prostate until simpler and alternative treatments were tried in the last two decades, particularly alpha(1) adrenoceptor-blocking agents. Tamsulosin is a potent, third-generation selective alpha(1A) adrenoceptor-blocking agent.
    [Abstract] [Full Text] [Related] [New Search]